Hashem Hasan, Sultan Iyad
Department of Pediatrics, Division of Pediatric Hematology-Oncology, King Hussein Cancer Center (KHCC), Amman, Jordan.
Pediatric Bone Marrow Transplantation and Stem Cell Therapy Service, King Hussein Cancer Center (KHCC), Amman, Jordan.
Front Med (Lausanne). 2025 May 19;12:1555893. doi: 10.3389/fmed.2025.1555893. eCollection 2025.
Artificial intelligence (AI) has recently garnered significant public attention. Among the various fields where AI can be applied, medicine stands out as one with immense potential. In particular, AI is transforming precision oncology by providing innovative approaches to customize cancer treatments for individual patients. This article examines the latest developments in AI-powered tools designed to improve cancer diagnosis accuracy and predict treatment outcomes. The integration of AI into precision oncology is transforming cancer care by enabling more personalized and effective treatments, minimizing treatment-related toxicities, and enhancing patient survival rates. As AI advances, it will be pivotal in developing more targeted and successful cancer therapies. The field is still in its early stages, and future progress will benefit from establishing standards and guidelines to promote rigorous methodological design and uphold ethical principles. This research highlights the transformative potential of AI in addressing the challenges posed by cancer heterogeneity.
人工智能（AI）最近引起了公众的广泛关注。在人工智能可应用的各个领域中，医学领域脱颖而出，具有巨大的潜力。特别是，人工智能正在通过提供创新方法来为个体患者定制癌症治疗方案，从而改变精准肿瘤学。本文探讨了旨在提高癌症诊断准确性和预测治疗结果的人工智能工具的最新发展。将人工智能整合到精准肿瘤学中正在改变癌症护理，实现更个性化、有效的治疗，最大限度地减少治疗相关毒性，并提高患者生存率。随着人工智能的发展，它将在开发更具针对性和更成功的癌症治疗方法方面发挥关键作用。该领域仍处于早期阶段，未来的进展将受益于建立标准和指南，以促进严谨的方法设计并坚持道德原则。这项研究突出了人工智能在应对癌症异质性带来的挑战方面的变革潜力。
